MedKoo Cat#: 414960 | Name: Pimobendan HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pimobendan HCl is a veterinary medication. Pimobendan is both a calcium sensitizer and a selective inhibitor of phosphodiesterase III (PDE3) with positive inotropic and vasodilator effects. Pimobendan is used in the management of heart failure in dogs, most commonly caused by myxomatous mitral valve disease (also previously known as endocardiosis), or dilated cardiomyopathy.Research has shown that pimobendan increases survival time and improves quality of life in canine patients with congestive heart failure secondary to mitral valve disease when compared with benazepril, an angiotensin-converting-enzyme (ACE) inhibitor.

Chemical Structure

Pimobendan HCl
Pimobendan HCl
CAS#77469-98-8 (HCl)

Theoretical Analysis

MedKoo Cat#: 414960

Name: Pimobendan HCl

CAS#: 77469-98-8 (HCl)

Chemical Formula: C19H19ClN4O2

Exact Mass: 0.0000

Molecular Weight: 370.84

Elemental Analysis: C, 61.54; H, 5.16; Cl, 9.56; N, 15.11; O, 8.63

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Pimobendan hydrochloride; Pimobendan HCl
IUPAC/Chemical Name
3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-6-yl)-5-methyl-, hydrochloride (1:1)
InChi Key
OJLOGBZTFKPHDQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H18N4O2.ClH/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12;/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24);1H
SMILES Code
O=C1CC(C)C(C2=CC=C3N=C(C4=CC=C(OC)C=C4)NC3=C2)=NN1.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 370.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Boyle KL, Leech E. A review of the pharmacology and clinical uses of pimobendan. J Vet Emerg Crit Care (San Antonio). 2012 Aug;22(4):398-408. doi: 10.1111/j.1476-4431.2012.00768.x. Review. PubMed PMID: 22928748. 2: Bowles D, Fry D. Pimobendan and its use in treating canine congestive heart failure. Compend Contin Educ Vet. 2011 Nov;33(11):E1. Review. PubMed PMID: 22101450. 3: Boswood A. Current use of pimobendan in canine patients with heart disease. Vet Clin North Am Small Anim Pract. 2010 Jul;40(4):571-80. doi: 10.1016/j.cvsm.2010.04.003. Review. PubMed PMID: 20610012. 4: Gordon SG, Miller MW, Saunders AB. Pimobendan in heart failure therapy--a silver bullet? J Am Anim Hosp Assoc. 2006 Mar-Apr;42(2):90-3. Review. PubMed PMID: 16527909. 5: Fuentes VL. Use of pimobendan in the management of heart failure. Vet Clin North Am Small Anim Pract. 2004 Sep;34(5):1145-55. Review. PubMed PMID: 15325474. 6: Kubo SH. Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Cardiology. 1997;88 Suppl 2:21-7. Review. PubMed PMID: 9142432. 7: Fitton A, Brogden RN. Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure. Drugs Aging. 1994 May;4(5):417-41. Review. PubMed PMID: 8043944. 8: Kubo SH. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan. Coron Artery Dis. 1994 Feb;5(2):119-26. Review. PubMed PMID: 8180743. 9: Hagemeijer F. Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure. Eur Heart J. 1993 Apr;14(4):551-66. Review. PubMed PMID: 8472722.